Komori
Shin Nippon Biomedical Laboratories (2395) · RiskRestated

Risks Related to Securing, Developing and Retaining Specialized Talent

First written in FY2016. 14 of 15 entries say "Restated". Latest entry: FY2026-H1.

15entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2026-H12016: 120162017: 120172018: 020182019: 120192020: 420202021: 220212022: 220222023: 220232024: 120242025: 12025
Same theme, other companies
Difficulty Securing, Developing and Retaining Specialized and Highly Skilled IT PersonnelA theme 544 companies write about · 559 as a headwind · 4 as a tailwind

The whole theme swung hardest in 2026: 36 of 111 companies on the "Worse" side.

100 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 190 companies compared. The sentences above are computed from all 190.Comparing 200 of the theme's 563 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「No new business or other risks arose during the current interim consolidated accounting period. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    専門人材の確保・育成・流出リスクについて、重要な変更がないと記載している。
  2. FY2024-Q3RestatedAnnual report

    「No new business or other risks arose during the nine-month period ended December 31, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    専門人材の確保・育成・流出リスクについて、重要な変更がないと記載している。
  3. FY2024-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    専門人材の確保・育成・流出リスクについて、重要な変更がないと記載している。
  4. FY2024-Q1RestatedAnnual report

    「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    専門人材の確保・育成・流出リスクについて、重要な変更がないと記載している。
  5. FY2023-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    専門人材の確保・育成・流出リスクについて、重要な変更がないと記載している。
  6. FY2022-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    専門人材の確保・育成・流出リスクについて、重要な変更がないと記載している。
  7. FY2021RestatedAnnual report

    「こうした人材の確保や教育研修が当社の計画どおりに進むという保証はなく、人員の確保、育成が順調に進まない場合、当社グループの事業推進に支障が生じ、当社グループの経営成績等に悪影響を及ぼす可能性があります。また、現在在籍するこれら人材の流出が生じた場合にも同様のリスクがあります。」

    専門人材、デジタル人材の確保・育成の遅れや流出、増員に伴う固定費負担を引き続きリスクとしている。
  8. FY2021-Q3RestatedAnnual report

    「No new business or other risks arose during the nine-month period ended December 31, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    専門人材の確保・育成・流出リスクについて、重要な変更がないと記載している。
  9. FY2021-Q2RestatedAnnual report

    「During the second quarter of the current consolidated cumulative period, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the securities report for the previous fiscal year.」

    専門人材の確保・育成・流出リスクについて、重要な変更がないと記載している。
  10. FY2021-Q1RestatedAnnual report

    「During the first quarter of the current consolidated cumulative period, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the securities report for the previous fiscal year.」

    専門人材の確保・育成・流出リスクについて、重要な変更がないと記載している。
  11. FY2020RestatedAnnual report

    「当社グループは今後も事業の拡大に伴い、積極的に人材の確保、育成を図る方針でありますが、こうした人材の確保や教育研修が当社の計画どおりに進むという保証はなく、人員の確保、育成が順調に進まない場合、当社グループの事業推進に支障が生じ、当社グループの経営成績等に悪影響を及ぼす可能性があります。」

    専門人材、デジタル人材の確保・育成の遅れや流出、増員に伴う固定費負担を引き続きリスクとしている。
  12. FY2020-Q3RestatedAnnual report

    「No new business or other risks arose during the nine-month period ended December 31, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    専門人材の確保・育成・流出リスクについて、重要な変更がないと記載している。
  13. FY2020-Q2RestatedAnnual report

    「During the second quarter of the current consolidated cumulative period, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the securities report for the previous fiscal year.」

    専門人材の確保・育成・流出リスクについて、重要な変更がないと記載している。
  14. FY2017RestatedAnnual report

    「こうした人材の確保や教育研修が当社の計画どおりに進むという保証はなく、人員の確保、育成が順調に進まない場合、当社グループの事業推進に支障が生じ、当社グループの経営成績等に悪影響を及ぼす可能性があります。」

    専門人材の確保・育成の遅れや流出、事業拡大に伴う固定費増加を引き続きリスクとしている。
  15. FY2016First statedAnnual report

    「こうした人材の確保や教育研修が当社の計画どおりに進むという保証はなく、人員の確保、育成が順調に進まない場合、当社グループの事業推進に支障が生じ、当社グループの経営成績等に悪影響を及ぼす可能性があります。」

    医学・薬学・化学・獣医学等の専門人材と有資格者の不足・流出、固定費増加を想定している。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Shin Nippon Biomedical Laboratories's next results are scheduled for 2026-11-10. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.